The guidance should help health systems safely manage and monitor AI tools in a financially sustainable manner, which can be ...

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...

With GLP-1 therapies representing one of the fastest-growing segments in the global pharmaceutical market, these results demonstrate that AI can now generate not only predictive but functionally ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

As pharmaceutical and medical device companies race to modernize how they engage doctors and patients, leaders face a central ...

Wandercraft announced that it secured $75 million in funding as part of its Series D financing round to support its robotic ...

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...

The Hill: FDA To Phase Out Some Animal Testing Requirements The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing ... using a range of approaches,” including ...